AnteoTechAnteoTechAnteoTechAnteoTech
  • Home
  • About
    • CASE STUDIES
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
  • Life Science
    • ANTEOBIND
    • ANTEOBIND PUBLICATIONS
    • BROCHURES
    • WEBINARS
  • Energy
  • COVID-19
  • Investors
    • LATEST NEWS
    • ASX Announcements
    • CORPORATE GOVERNANCE & COMPANY POLICY
    • VIEW ON ASX
  • Contact

AnteoTech freeze design of COVID19 test

    Home announcements AnteoTech freeze design of COVID19 test
    NextPrevious

    AnteoTech freeze design of COVID19 test

    By AnteoTech | 2020 Announcements | Comments are Closed | 26 November, 2020 |

    AnteoTech Ltd  is pleased to announce that all development processes and internal testing procedures for the high sensitivity COVID-19 Antigen Rapid Test (ART) are complete and the Company has declared a “design freeze” for the product.

    20201126 Design freeze of COVID 19 test
    No tags.

    NextPrevious

    Quick Links

    • About
    • Life Science
    • Energy
    • Investors

    Investors

    • Investor Information
    • Latest News
    • Corporate Governance & Company Policy

    Contact Us

    If you have any general questions about our products or technology, contact customer support on (07) 3219 0085 or email contact@anteotech.com. For all technical support, please email support@anteotech.com.

    For all investor-related queries please email investors@anteotech.com.

    Copyright © AnteoTech 2020. All rights reserved. AnteoCoat/AnteoBind are trademarks of the AnteoTech group of companies. All other trademarks referenced are owned by their respective companies.
    Website by Start Digital
    • Home
    • About
      • CASE STUDIES
      • MANAGEMENT TEAM
      • BOARD OF DIRECTORS
    • Life Science
      • ANTEOBIND
      • ANTEOBIND PUBLICATIONS
      • BROCHURES
      • WEBINARS
    • Energy
    • COVID-19
    • Investors
      • LATEST NEWS
      • ASX Announcements
      • CORPORATE GOVERNANCE & COMPANY POLICY
      • VIEW ON ASX
    • Contact
    AnteoTech